Pain Therapeutics, Inc. announced it has been awarded $1.5 million in research funding from the National Institutes of Health (NIH). Today’s grant award is intended to support, over the next eighteen months, the Company’s on-going development of new technology to detect Alzheimer’s disease with a simple blood test.